C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis (Q33901646)

29 July 2017

C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis (English)

1 reference

29 July 2017

0 references

1 reference

11

Frank C Sciurba

1 reference

29 July 2017

Kusum V Pandit

3

0 references

Naftali Kaminski

object named as

Naftali Kaminski

10

0 references

author name string

Louis J Vuga

1

1 reference

29 July 2017

John R Tedrow

2

1 reference

29 July 2017

Jiangning Tan

4

1 reference

29 July 2017

Daniel J Kass

5

1 reference

29 July 2017

Jianmin Xue

6

1 reference

29 July 2017

Divay Chandra

7

1 reference

29 July 2017

Joseph K Leader

8

1 reference

29 July 2017

Kevin F Gibson

9

1 reference

29 July 2017

Steven R Duncan

12

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 2014

1 reference

American Journal of Respiratory and Critical Care Medicine

29 July 2017

1 reference

29 July 2017

189

1 reference

29 July 2017

8

1 reference

29 July 2017

966-974

1 reference

Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Bronchus-associated lymphoid tissue in pulmonary hypertension produces pathologic autoantibodies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Identification of periplakin as a new target for autoreactivity in idiopathic pulmonary fibrosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Idiopathic pulmonary fibrosis-an epidemiological and pathological review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Acute cellular rejection and humoral sensitization in lung transplant recipients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Identification of annexin 1 as a novel autoantigen in acute exacerbation of idiopathic pulmonary fibrosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Autoantibodies in patients with chronic obstructive pulmonary disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Acute exacerbations of idiopathic pulmonary fibrosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

B cells move to centre stage: novel opportunities for autoimmune disease treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Lymphoid neogenesis in chronic inflammatory diseases.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Detection of antivimentin antibody in sera of patients with idiopathic pulmonary fibrosis and non-specific interstitial pneumonia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Upregulation of tenascin and TGFbeta production in a type II alveolar epithelial cell line by antibody against a pulmonary auto-antigen

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Chemokines, chemokine receptors, and allograft rejection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Use of combined plasmapheresis and immunosuppression in the treatment of Goodpasture's syndrome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension.

5 July 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1592OC

Rituximab treatment of the anti-synthetase syndrome: a retrospective case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1592OC

Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1592OC

CXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1592OC

Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1592OC

Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1592OC

Autoantibodies to IL-1 alpha in sera from rapidly progressive idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4098096

Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy

29 October 2018

1 reference

12 December 2020

Elevation of anti-cytokeratin 18 antibody and circulating cytokeratin 18: anti-cytokeratin 18 antibody immune complexes in sera of patients with idiopathic pulmonary fibrosis

1 reference

12 December 2020

Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing

1 reference

12 December 2020

Study of immune complexes in bronchoalveolar lavage fluids

1 reference

12 December 2020

Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor

1 reference

12 December 2020

10.1164/RCCM.201309-1592OC

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference